Aurinia Pharmaceuticals
Trade Aurinia Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AUPH
Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
AUPH Key Statistics
Stock Snapshot
Aurinia Pharmaceuticals(AUPH) stock is priced at $16.50, giving the company a market capitalization of 2.2B. It carries a P/E multiple of 7.26.
During the trading session on 2026-10-17, Aurinia Pharmaceuticals(AUPH) shares reached a daily high of $16.81 and a low of $16.35. At a current price of $16.50, the stock is +0.9% higher than the low and still -1.8% under the high.
Trading activity shows a volume of 737.55K, compared to an average daily volume of 865.56K.
Over the past 52 weeks, Aurinia Pharmaceuticals(AUPH) stock has traded between a high of $19.25 and a low of $11.30.
Over the past 52 weeks, Aurinia Pharmaceuticals(AUPH) stock has traded between a high of $19.25 and a low of $11.30.
Analyst ratings
67%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.